These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 3318824

  • 1. Improvement of cytotoxicity of tumor necrosis factor (TNF) by increase in basicity of its N-terminal region.
    Soma G, Kitahara N, Tsuji Y, Kato M, Oshima H, Gatanaga T, Inagawa H, Noguchi K, Tanabe Y, Mizuno D.
    Biochem Biophys Res Commun; 1987 Oct 29; 148(2):629-35. PubMed ID: 3318824
    [Abstract] [Full Text] [Related]

  • 2. Biological activities of novel recombinant tumor necrosis factor having N-terminal amino acid sequences derived from cytotoxic factors produced by THP-1 cells.
    Soma G, Tsuji Y, Tanabe Y, Noguchi K, Kitahara-Tanabe N, Gatanaga T, Inagawa H, Kawakami M, Mizuno D.
    J Biol Response Mod; 1988 Dec 29; 7(6):587-95. PubMed ID: 2851034
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity.
    Havell EA, Fiers W, North RJ.
    J Exp Med; 1988 Mar 01; 167(3):1067-85. PubMed ID: 3351434
    [Abstract] [Full Text] [Related]

  • 8. Comparison of recombinant tumor necrosis factor and the monocyte-derived cytotoxic factor involved in monocyte-mediated cytotoxicity.
    Nissen-Meyer J, Austgulen R, Espevik T.
    Cancer Res; 1987 May 01; 47(9):2251-8. PubMed ID: 3567918
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antitumor effect of systemic administration of novel recombinant tumor necrosis factor (rTNF-S) with less toxicity than conventional rTNF-alpha in vivo.
    Gatanaga T, Noguchi K, Tanabe Y, Inagawa H, Soma G, Mizuno D.
    J Biol Response Mod; 1989 Jun 01; 8(3):278-86. PubMed ID: 2746298
    [Abstract] [Full Text] [Related]

  • 11. Preparation and characterization of PEGylated adducts of recombinant human tumor necrosis factor-alpha from Escherichia coli.
    Li W, Wang Y, Zhu X, Li M, Su Z.
    J Biotechnol; 2002 Jan 18; 92(3):251-8. PubMed ID: 11689249
    [Abstract] [Full Text] [Related]

  • 12. Cloning and expression of the cDNA for canine tumor necrosis factor-alpha in E. coli.
    Zucker K, Lu P, Fuller L, Asthana D, Esquenazi V, Miller J.
    Lymphokine Cytokine Res; 1994 Jun 18; 13(3):191-6. PubMed ID: 7948427
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Induction of differentiation of human monoblastic and myeloblastic leukemia cell lines by TNF muteins.
    Kamijo R, Takeda K, Nagumo M, Konno K, Hasegawa A, Inaka K, Ikehara M.
    Biochem Biophys Res Commun; 1989 Apr 28; 160(2):820-7. PubMed ID: 2541714
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intracellular cAMP regulates the cytotoxicity of recombinant tumor necrosis factor for L cells in vitro.
    Chun M, Hoffmann MK.
    Lymphokine Res; 1987 Apr 28; 6(3):161-7. PubMed ID: 3041126
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.